XIAP reduces muscle proteolysis induced by CKD

Journal of the American Society of Nephrology

Volumn 21, Issue 7, 2010, Pages 1174-1183

  Hu, Junping ^a   Du, Jie ^b   Zhang, Liping ^b   Price, S Russ ^a   Klein, Janet D ^a   Wang, Xiaonan H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ATROGIN 1; CASPASE 3; CHYMOTRYPSIN; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; PROTEASOME; PROTEIN KINASE B; UBIQUITIN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GENE OVEREXPRESSION; KIDNEY FUNCTION; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE HYPERTROPHY; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE;

EID: 77954569903     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009101011     Document Type: Article

References (57)

1. Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE: Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 113: 115-123, 2004 (Pubitemid 38541638)
2. Siu PM, Alway SE: Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle. J Physiol 565: 309-323, 2005
3. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 67: 563-568, 1981
4. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97: 1447-1453, 1996 (Pubitemid 26097034)
5. Clowes GH Jr, George BC, Villee CA Jr, Saravis CA: Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 308: 545-552, 1983
6. Costelli P, Carbo N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Argiles JM, Baccino FM: Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92: 2783-2789, 1993 (Pubitemid 2002760)
7. Price SR, Bailey JL, Wang X, Jurkovitz C, England BK, Ding X, Phillips LS, Mitch WE: Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest 98: 1703-1708, 1996 (Pubitemid 26359185)
8. Wang X, Hu Z, Hu J, Du J, Mitch WE: Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147: 4160-4168, 2006 (Pubitemid 44268367)
9. Mansoor O, Beaufrere B, Boirie Y, Ralliere C, Taillandier D, Aurousseau E, Schoeffler P, Arnal M, Attaix D: Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci U S A 93: 2714-2718, 1996
10. Fang CH, Tiao G, James H, Ogle C, Fischer JE, Hasselgren PO: Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J Am Coll Surg 180: 161-170, 1995
11. Reeds DN, Cade WT, Patterson BW, Powderly WG, Klein S, Yarasheski KE: Whole-body proteolysis rate is elevated in HIV-associated insulin resistance. Diabetes 55: 2849-2855, 2006 (Pubitemid 44923686)
12. Vescovo G, Volterrani M, Zennaro R, Sandri M, Ceconi C, Lorusso R, Ferrari R, Ambrosio GB, Dalla Libera L: Apoptosis in the skeletal muscle of patients with heart failure: Investigation of clinical and biochemical changes. Heart 84: 431-437, 2000
13. Libera LD, Zennaro R, Sandri M, Ambrosio GB, Vescovo G: Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am J Physiol 277: C982-C986, 1999
14. Pupim LB, Heimburger O, Qureshi AR, Ikizler TA, Stenvinkel P: Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int 68: 2368-2374, 2005 (Pubitemid 43117817)
15. Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 50: 343-357, 1996
16. Kopple JD: National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 37[Suppl 2]: S66-S70, 2001 (Pubitemid 32048027)
17. Avram MM, Mittman N: Malnutrition in uremia. Semin Nephrol 14: 238-244, 1994
18. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003 (Pubitemid 36043346)
19. Garg AX, Papaioannou A, Ferko N, Campbell G, Clarke JA, Ray JG: Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int 65: 649-653, 2004 (Pubitemid 38130661)
20. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, Goldberg AL: Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004 (Pubitemid 38076464)
21. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001
22. Solomon V, Goldberg AL: Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 271: 26690-26697, 1996 (Pubitemid 26359075)
23. Fagan JM, Waxman L, Goldberg AL: Skeletal muscle and liver contain a soluble ATP + ubiquitin-dependent proteolytic system. Biochem J 243: 335-343, 1987 (Pubitemid 17072831)
24. Sandri M: Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23: 160-170, 2008
25. Workeneh BT, Rondon-Berrios H, Zhang L, Hu Z, Ayehu G, Ferrando A, Kopple JD, Wang H, Storer T, Fournier M, Lee SW, Du J, Mitch WE: Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol 17: 3233-3239, 2006 (Pubitemid 44707785)
26. Holcik M, Korneluk RG: XIAP, the guardian angel. Nat Rev Mol Cell Biol 2: 550-556, 2001
27. Suzuki Y, Nakabayashi Y, Takahashi R: Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A 98: 8662-8667, 2001 (Pubitemid 32678084)
28. Wang XH, Hu J, Du J, Klein JD: X-chromosome linked inhibitor of apoptosis protein inhibits muscle proteolysis in insulin-deficient mice. Gene Ther 14: 711-720, 2007 (Pubitemid 46585652)
29. Birkey Reffey S, Wurthner JU, Parks WT, Roberts AB, Duckett CS: X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling. J Biol Chem 276: 26542-26549, 2001 (Pubitemid 37412876)
30. Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K, Ueno N, Nishida E, Shibuya H, Matsumoto K: XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 18: 179-187, 1999 (Pubitemid 29005034)
31. Asselin E, Wang Y, Tsang BK: X-linked inhibitor of apoptosis protein activates the phosphatidylinositol 3-kinase/Akt pathway in rat granulosa cells during follicular development. Endocrinology 142: 2451-2457, 2001 (Pubitemid 32473101)
32. Gao Y, Ordas R, Klein JD, Price SR: Regulation of caspase-3 activity by insulin in skeletal muscle cells involves both PI3-kinase and MEK-1/2. J Appl Physiol 105: 1772-1778, 2008
33. Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE: Chronic kidney disease causes defects in signaling through the insulin receptor substrate/ phosphatidylinositol 3-kinase/Akt pathway: Implications for muscle atrophy. J Am Soc Nephrol 17: 1388-1394, 2006 (Pubitemid 43673419)
34. Franch HA, Raissi S, Wang X, Zheng B, Bailey JL, Price SR: Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: Consequences on proteolysis. Am J Physiol Renal Physiol 287: F700-F706, 2004 (Pubitemid 39280504)
35. Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14: 2366-2372, 2003 (Pubitemid 37069205)
36. Kakiya R, Shoji T, Tsujimoto Y, Tatsumi N, Hatsuda S, Shinohara K, Kimoto E, Tahara H, Koyama H, Emoto M, Ishimura E, Miki T, Tabata T, Nishizawa Y: Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int 70: 549-556, 2006 (Pubitemid 44141582)
37. Yasuhara S, Perez ME, Kanakubo E, Yasuhara Y, Shin YS, Kaneki M, Fujita T, Martyn JA: Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab 279: E1114-E1121, 2000
38. McClung JM, Kavazis AN, DeRuisseau KC, Falk DJ, Deering MA, Lee Y, Sugiura T, Powers SK: Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy. Am J Respir Crit Care Med 175: 150-159, 2007 (Pubitemid 46115086)
39. Plant PJ, Bain JR, Correa JE, Woo M, Batt J: Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy. J Appl Physiol 107: 224-234, 2009
40. Supinski GS, Wang W, Callahan LA: Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness. J Appl Physiol 107: 1389-1396, 2009
41. Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, Mitch WE: IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 20: 604-612, 2009
42. Vazeille E, Codran A, Claustre A, Averous J, Listrat A, Bechet D, Taillandier D, Dardevet D, Attaix D, Combaret L: The ubiquitin-proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy. Am J Physiol Endocrinol Metab 295: E1181-E1190, 2008
43. Deveraux QL, Takahashi R, Salvesen GS, Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304, 1997 (Pubitemid 27317977)
44. Huang Y, Park YC, Rich RL, Segal D, Myszka DG, Wu H: Structural basis of caspase inhibition by XIAP: Differential roles of the linker versus the BIR domain. Cell 104: 781-790, 2001
45. Witt SH, Granzier H, Witt CC, Labeit S: MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: Towards understanding MURF-dependent muscle ubiquitination. J Mol Biol 350: 713-722, 2005
46. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E, Glass DJ: The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 6: 376-385, 2007
47. McElhinny AS, Kakinuma K, Sorimachi H, Labeit S, Gregorio CC: Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J Cell Biol 157: 125-136, 2002
48. Cohen S, Brault JJ, Gygi SP, Glass DJ, Valenzuela DM, Gartner C, Latres E, Goldberg AL: During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J Cell Biol 185: 1083-1095, 2009
49. Lee SW, Dai G, Hu Z, Wang X, Du J, Mitch WE: Regulation of muscle protein degradation: Coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol 15: 1537-1545, 2004
50. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL: Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004 (Pubitemid 38534545)
51. Zheng B, Ohkawa S, Li H, Roberts-Wilson TK, Price SR: FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy. FASEB J 2010, in press
52. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, Tsang BK, Cheng JQ: Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279: 5405-5412, 2004 (Pubitemid 38220563)
53. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR: A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559-569, 1998 (Pubitemid 128379082)
54. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N: Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27: 195-200, 2001 (Pubitemid 32157448)
55. Dunant P, Larochelle N, Thirion C, Stucka R, Ursu D, Petrof BJ, Wolf E, Lochmuller H: Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic MDX mice. Mol Ther 8: 80-89, 2003 (Pubitemid 36939299)
56. Zhou Q, Du J, Hu Z, Walsh K, Wang XH: Evidence for adipose-muscle cross talk: Opposing regulation of muscle proteolysis by adiponectin and fatty acids. Endocrinology 148: 5696-5705, 2007 (Pubitemid 350146142)
57. Kisselev AF, Goldberg AL: Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol 398: 364-378, 2005 (Pubitemid 41578898)